Cingulate is a biopharmaceutical company creating a pipeline of next-generation treatments utilizing its innovative Precision Timed Release™ technology.
Joined September 2021
- Tweets 96
- Following 167
- Followers 336
- Likes 12
71 Photos and videos
29 Jul 2025
Exciting News from Cingulate: We’ve received a $4.3M PDUFA fee waiver from the FDA ahead of our imminent NDA submission for CTx-1301, our lead asset for the treatment of ADHD.
Learn more: finance.yahoo.com/news/cingu…
#CTx1301 #ADHD #FDA #PDUFA #NDA #CING #PrecisionTimedRelease #PTR
2
4
15
1,303
10 Jul 2025
We’re excited to welcome Nilay Patel, JD as our Chief Legal Officer! Nilay brings deep legal expertise and a strategic understanding of the complexities of pharma commercialization.
#PharmaLaw #ADHD #Cingulate #Innovation #CING #Nasdaq #ADHDtreatment
finance.yahoo.com/news/cingu…
3
6
1,028
18 Jun 2025
📢 Stonegate Capital Partners has initiated coverage on Cingulate (NASDAQ: CING) with a valuation range of $13.96–$26.96.
Read the announcement and full report: finance.yahoo.com/news/stone…
#CING #ADHD #CTX1301 #NDASubmission #StonegateCapitalPartners
3
7
1,715
12 Jun 2025
#ICMYI: Congress held a key hearing this week on strengthening U.S. manufacturing and supply chain security. 🇺🇸
youtube.com/watch?v=eXkAOKwv…
CING proudly supports onshoring and ensuring patient access to ADHD meds.
#adhd #cing #SupplyChainSecurity #onshoring
3
5
702
29 May 2025
#ICMYI Cingulate CEO Shane Schaffer outlines CING’s plans to commercialize CTx-1301 and explains why Indegene is the perfect partner to bring CING’s lead ADHD asset to market.
#Cingulate #CING #Commercialization #ADHD
youtube.com/watch?v=JLfjj5lO…
4
11
866
27 May 2025
What does an ADHD diagnosis mean to you? Cingulate CEO Shane Schaffer explores the wide spectrum of those living with ADHD and the unique paths they take on their journey.
#ADHD #CING #Cingulate #Nasdaq
youtu.be/-MPXRIvbvwY
2
6
522
22 May 2025
#ICYM : Cingulate announced phase 3 pediatric efficacy results for CTX-1301. CEO Shane Schaffer joined Zacks analyst John Vandermosten on the Unboxing Biotechpodcast.
#Cingulate #biotech #efficacyresults #CING #Nasdaq
youtu.be/trHIjzvRAvs
2
6
411
14 May 2025
Business Development and Licensing joins our CEO to discuss Cingulate's strategic roadmap.
#BusinessDevelopment
#Licensing
#Cingulate
#CingulateInc
#StrategicRoadmap
#PharmaStrategy
youtu.be/9hxJeZWg6kE
4
6
476
7 May 2025
How Did Cingulate Begin? CEO Shane Schaffer Shares the Story.
#CING #ADHD #CompanyOrigins #PharmaInnovation
#Biotech #CEOInsights #Cingulate
youtu.be/5vAWMCb5VMg
1
2
2
350
22 Apr 2025
Inside Cingulate: A Conversation with the Board of Directors.
#BoardOfDirectors
#ExecutiveLeadership
#Cingulate #CING #NASDAQ
#Corporateinsights
youtu.be/tRLD7RTELd8
1
4
213
16 Apr 2025
Behind Closed Doors: Big Biz Show Gets Inside Look at Cingulate Board Meeting.
#BigBizShow
#Cingulate
#CingulateNews
#InsideCingulate
#BigBizExclusive
youtu.be/_eOP5k6wnaU
3
6
271
7 Apr 2025
CEO Shane Schaffer recently shared insights at the 2025 Roth Conference with Big Biz Show Analyst Howie Font, including investor sentiment, near-term milestones, and the future of PTR. #rothconference #investors#FutureGrowth #PTR #BigBiz
youtu.be/wbBPPaBEbUE
2
4
434
18 Mar 2025
Overcoming the Unmet Needs of ADHD: Cingulate CEO Shane Schaffer Discusses the Safety Profile of CTx-1301 and more on the Big Biz Show.
#adhd #cingulate #cingulate #NASDAQ
youtu.be/KewFI7asRTc
3
3
309
10 Mar 2025
Why are stimulants the most effective way of treating ADHD?
The Science Behind ADHD Treatment: Cingulate Inc.'s CEO Shane Schaffer and CMO Matthew Brams on the Big Biz Show.
#ADHD #CING #Cingulate #Stimulants #Treatment
youtu.be/WaJlMpOtjFw?si=2_59…
3
5
308
21 Jan 2025
What does entire active day coverage mean to you? CEO Shane Schaffer discusses Cingulate’s lead ADHD asset CTx-1301 with life sciences analyst John Vandermosten below.
youtube.com/watch?v=K-pdLTsz…
#ADHD #CING #Cingulate #nasdaq
5
5
308
14 Jan 2025
Cingulate CEO Shane Schaffer recently sat down with “Unboxing Biotech” host John Vandermosten for a wide-ranging interview. In this excerpt Schaffer maps out CING’s timeline to NDA submission for lead ADHD asset CTx-1301.
#adhd #CING #Nasdaq #Cingulate
youtube.com/watch?v=qiWp2f-B…
3
5
310
8 Jan 2025
CING CEO Shane Schaffer recently joined the Big Biz Show in-studio to discuss the genesis of CING and the evolution of its Precision Timed Release™ drug delivery platform. Watch part one of the interview here.
youtu.be/I61s2TISXwo
#adhd
#cing
#cingulate
#adhdawareness
4
4
236
13 Nov 2024
Cingulate's Shane Schaffer went LIVE in studio with the Big Biz Show.
A shout-out to Sully & crew for their amazing hospitality and continued interest in CING!
Visit cingulate.com for updates!
#cingulate #adhd #cing #adhdawareness
youtu.be/qZrI3iPzpSQ
3
6
331
6 Nov 2024
Shane Schaffer, CEO of Cingulate Inc, recently rejoined The Big Biz Show to discuss some exciting upcoming company milestones! 🚀
A big thank you to The Big Biz Show crew for hosting!
#TheBigBizShow #cing #Cingulate #adhd #nasdaq
youtu.be/56eNR0azJz0
1
3
3
441